Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
Last week, we reported on a study published in JAMA Network Open that examined the association of population-level measures of wellbeing with rates of mortality from cardiovascular disease (CVD) in the US.
The study
Investigators conducted a cross-sectional study and linked data from the Gallup National Health and Well-Being Index (WBI) sruvey to county-level rates of CVD mortality from the Centers for Disease Control and Prevention Atlas of Heart Disease and Stroke. Gallup conducted the WBI survey among randomly selected US adults aged ≥18 years from 2015 to 2017 (analyzed from August 2022 to May 2023).
The WBI is comprised of 5 elements of wellbeing and scored on a scale of 0 to 100, with 0 being the lowest well-being and 100 being the highest. The 5 elements:
having a successful life career
social relationships
financial security
relationship to community
good physical health
The study's primary outcome was the county-level rate of total CVD mortality; secondary outcomes were mortality rates for stroke, heart failure (HF), coronary heart disease, acute myocardial infarction (MI), and total heart disease.
The findings
Overall, the team observed wellbeing scores that were “marginally but statistically lower” among counties where income inequality was greater, and deprivation was more pronounced. Wellbeing scores were similarly lower in counties where rates of hypertension, diabetes, physical inactivity, obesity, and smoking were higher.
Population wellbeing was inversely associated with CVD mortality rate with the overall mortality rate reported as 462 deaths per 100 000 persons.
Reporting on the primary outcome, researchers found that CVD mortality rates decreased from a mean of 499.7 (range, 174.2-974.7) deaths/100 000 in counties with the lowest quintile of population wellbeing to 438.6 (range, 110.1-850.4) deaths/100 000 in counties where population wellbeing was in the highest quintile—a difference of 61.1 deaths/100 000 between counties with the highest and lowest WBI values.
The effect size of WBI on CVD mortality before adjustment was −15.5 (1.5; P< .001), ie, a decrease of 15 deaths/100 000 persons for each 1-point increase of population wellbeing. Deaths from all heart disease were identified as mediating the association and stroke to a lesser degree.
A note from authors
"These findings suggest that population well-being is a measurable and modifiable metric that may offer a focus of immediate intervention to improve cardiovascular health outcomes."
AHA 2026: Yoga-based cardiac rehabilitation improved quality of life and walking distance in patients with HFrEF but did not significantly reduce death, hospitalization, or stroke.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Survodutide demonstrated cardiovascular safety vs placebo in the phase 3 SYNCHRONIZE-CVOT trial, with improvements in weight and cardiometabolic risk factors.
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.